AzTrials
AzTrials

Muscle OxygenationNCT06906146

Capacitive Resistive Electric Transfer Therapy on Muscle Recovery

A study testing CRET therapy in people with Muscle Oxygenation and Lactate, run by Universitat Internacional de Catalunya.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of Capacitive Resistive Electric Transfer (CRET) therapy combined with post-competition massage in the recovery and muscle function of professional athletes. It is designed as a randomized, double-blind, crossover clinical trial. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Oxygenation, Lactate, Anaerobic Exercise
What is being tested?
CRET therapy
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
No sites listed yet
Study dates
10 Apr 2025to 10 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Athletes who practice a type of sport that requires the use of anaerobic muscle metabolism (cycling, athletics, triathlon, crossfit, spinning and duathlon)
  • Athletes must be federated and train a minimum of 4 days/week
  • Active participation in regional, national or international competitions.

Who cannot join

  • Volunteers who have suffered a sports injury that makes it impossible for them to perform the test
  • Having received the CRET therapy technique.
  • Subjects who report allergies to the conductive cream.
  • Subjects undergoing pharmacological medical treatment that may interfere with the measurements.

About this study

Official title: Effectivness of Capacitive Resistive Electric Transfer Therapy on Muscle Recovery in Athletes

This study aims to evaluate the effectiveness of Capacitive Resistive Electric Transfer (CRET) therapy combined with post-competition massage in the recovery and muscle function of professional athletes. It is designed as a randomized, double-blind, crossover clinical trial. The primary objective is to analyze the efficacy of this combined protocol in muscle recovery after performing the Wingate anaerobic power and capacity test. Secondary objectives include assessing changes in muscle fatigue, muscle function of the rectus femoris and vastus lateralis, physiological changes in blood lactate concentration and oxygen saturation, and intramuscular structural changes through ultrasound before and after the intervention.

The study will recruit professional athletes from disciplines that require anaerobic muscle metabolism, such as cycling, athletics, triathlon, CrossFit, and duathlon. Participants must be federated athletes who train at least four times per week and actively compete at regional, national, or international levels. Exclusion criteria include recent sports injuries preventing test performance, prior exposure to CRET therapy, allergies to conductive gel, language barriers, participation in other research studies, or ongoing pharmacological treatment that could interfere with measurements.

Read more

Participants will attend four study sessions, divided into two sets of two consecutive days. On the first day, they will perform the Wingate test followed by the assigned post-competition massage with either CRET therapy or a placebo intervention. On the second day, they will repeat the Wingate test. After a three-week washout period, participants will switch to the opposite group. The intervention group will receive a 60-minute CRET therapy session with both resistive and capacitive modes applied at different power intensities, combined with a standardized recovery massage. The placebo group will receive the same massage while undergoing a simulated CRET therapy, with the machine turned on but without power application to prevent participant awareness of the placebo condition.

The study will analyze various dependent variables, including Wingate test performance, blood lactate levels, subjective fatigue perception using the modified Borg scale, muscle stiffness and tone through myotonometry, muscle oxygen saturation via near-infrared spectroscopy (NIRS), cross-sectional muscle area and grayscale values from ultrasound imaging, body composition using a Tanita analyzer, maximum isometric quadriceps strength via handheld dynamometry, and muscle activity measured by surface electromyography (sEMG). Each of these variables will be assessed at specific time points before, during, and after the intervention.

The estimated sample size is approximately 50 subjects, with 25 participants per group, determined through a preliminary pilot study. Statistical analyses will be conducted using IBM SPSS Statistics 26.0. Descriptive statistics will be calculated for quantitative and qualitative variables. A linear mixed model will be applied to compare changes between and within groups over five measurement periods using a one-way mixed ANOVA. If the sphericity assumption is violated, the Greenhouse-Geisser correction will be applied. Statistically significant effects will undergo post-hoc analysis with Bonferroni correction for multiple comparisons. All originally enrolled participants will be included in the final analysis following an intention-to-treat approach, and effect sizes will be calculated using eta squared. The significance level will be set at p < 0.05.

Being tested
CRET therapy, Sham CRET Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CRET therapyDevice

    Capacitive Resistive Electric Transfer (CRET) therapy is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, enhance blood circulation, and reduce muscle pain. It operates through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures like tendons, ligaments, and joints. This technique is widely used in rehabilitation, sports physiotherapy, and pain management to accelerate muscle recovery and optimize neuromuscular function.

  • Sham CRET TherapyDevice

    Same as CRET therapy but in a aham form.

Study groups in NCT06906146
Study groupRoleWhat they receive
CRET therapyExperimentalNot described
Receives: Device: CRET therapy
ShamSham comparatorNot described
Receives: Device: Sham CRET Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lactate

    Capacitive resistive electrical transfer therapy (CRET) is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, improve blood circulation and reduce muscle pain. It works through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures such as tendons, ligaments and joints. This technique is widely used in rehabilitation, sports physiotherapy and pain management to accelerate muscle recovery and optimize neuromuscular function.

    Measured: 1 hour after the test

Secondary outcomes (5)
  1. Wingate Test

    The Wingate test is used to determine power and anaerobic capacity (21). Each subject will perform the test: 30 seconds at maximum intensity interspersed with 1 minute of active recovery (pedaling 100 rpm), and this cycle will be repeated 3 times. The cycloergometer (Monark 818E, Vansbro, Sweden) will be used.

    The test will be performed with a flywheel load resistance calculated based on 0.075 kg of the subject's current body weight. Heart rate during the test will be monitored with a heart rate monitor (Polar CS100 Cycling Heart Rate Monitor).

    Measured: During the test

  2. Muscle oxygen saturation percentage

    Near infrared spectroscopy (NIRS) monitoring detects changes in tissue oxygenation in small blood vessels, capillaries and oxygen transport (e.g. myoglobin). This instrument determines the relationship between oxyhemoglobin concentration and total hemoglobin concentration in the muscle. The sensors will be attached to the vastus lateralis and rectus femoris muscles during the Wingate test.

    Measured: During the test

  3. Muscle thickness

    Ultrasound (US) images were used (US Aloka Prosound C3 15.4) with a high-frequency linear transducer (USTTL01, 12 L5), measured by a researcher with more than 10 years of experience handling the instrument. Measurements were taken in the muscle belly of the vastus lateralis (i.e., in the same location as the NIRS measurements) and the rectus femoris, with the patient lying on the examination table, knees fully extended, and legs without rotation. Ultrasound imaging was always performed at the same point (marked with a dermographic pen), with the linear transducer placed at the same angle (perpendicular to the skin). The 90º angulation of the transducer was verified before each measurement using a goniometer. The transducer was positioned without applying force to the skin, merely making contact with the ultrasound gel. Ultrasound device settings were adjusted for each patient to optimize the visualization of the target tissue, and the same settings were maintained for all measurements

    Measured: 1 hour after the test

  4. Maximal voluntary knee extension force

    before (at rest) and the day after (24h after the end of the Wingate test and recovery intervention), subject performed a 5s isometric maximal voluntary contraction to measure the maximal voluntary force of the knee extensor muscles. The force was registered in the dominant lower limb and the unit of measure was Newtons. A traction dynamometer (PCE Ibérica S.L., Albacete, Spain) was used. During the assessment, participants were seated with their hips and knees flexed at a 90o angle, and a strap was secured on the distal and anterior part of the dominant leg. The test was repeated three times, and the mean value was used for the analysis. Verbal encouragements were given throughout the contraction time.

    Measured: Before the test

  5. muscle activity

    muscle activity was recorded using surface electromyography from vastus lateralis and rectus femoris. The data was obtained by consists of three parts: (a) a Shimmer3 sEMG unit (Realtime Technologies Ltd., Dublin, Ireland). The signal was smoothed using a window size of 0.025s root mean square (RMS) and an overlapping of 0.0125s between windows. The Maximal Voluntary Isometric Contraction (MVIC) was calculated using the peak of the RMS signal during the extension knee isometric test. The RMS was the principal variable recorded for muscle activity. The participants' skin was cleaned with alcohol and dried before the electrodes were placed. If hair impeded the correct adhesion of the electrodes to the skin, the particular site was shaved. Self-adhesive 5×5 cm Valutrode® surface electrodes were placed on the muscle bellies according to the SENIAM project recommendations and with an interelectrode distance of 20 mm. Vastus lateralis electrodes were placed between the line from

    Measured: Before the test

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2025
  2. Study start10 Apr 2025 (estimated)
  3. Primary completion10 May 2025 (estimated)
  4. Study completion10 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06906146
Sponsor's protocol ID
CBAS-2023-03
Status last verified
Mar 2025
First submitted
6 Mar 2025
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Canet-Vintro M, Oviedo GR, Lopez-de-Celis C, Beltrame T, Muniz-Pardos B, Mengual I, Rodriguez-Sanz J. Muscle Massage Adding Capacitive Resistive Electric Transfer Therapy in Active or Sham Condition for Post-Exercise Recovery in Athletes: A Crossover Clinical Trial. Eur J Sport Sci. 2026 Oct;26(10):e70246. doi: 10.1002/ejsc.70246.

    PubMed 42733310

Questions about this trial

What is this clinical trial studying?

A study testing CRET therapy in people with Muscle Oxygenation and Lactate, run by Universitat Internacional de Catalunya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lactate (time frame: 1 hour after the test). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06906146, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in